Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Science Translational Medicine|December 22, 2021
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemiaQian Zhang, Morgan E Hresko, Lora K Picton, et al.
Scientific Reports|April 21, 2018
The CPT1a inhibitor, etomoxir induces severe oxidative stress at commonly used concentrationsRoddy S O'Connor, Lili Guo, Saba Ghassemi, et al.
The American Journal of Pathology|May 31, 2022
Induction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Oncogenic Kinase NPM-ALKQian Zhang, Hong Y Wang, Anindita Nayak, et al.
The Journal of Clinical Investigation|August 21, 2020
Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgarisJinmin Lee, Daniel K Lundgren, Xuming Mao, et al.
Haematologica|March 17, 2018
Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cellsMaria Krevvata, Xiaochuan Shan, Chenghui Zhou, et al.
Blood Advances|May 12, 2023
CD38 as a pan-hematologic target for chimeric antigen receptor T cellsTina Glisovic-Aplenc, Caroline Diorio, John A Chukinas, et al.
Nature Biomedical Engineering|February 22, 2022
Rapid manufacturing of non-activated potent CAR T cellsSaba Ghassemi, Joseph S Durgin, Selene Nunez-Cruz, et al.
Leukemia|September 29, 2023
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic functionQian Zhang, Johnvesly Basappa, Hong Y Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell LymphomaMarco Ruella, Saad S Kenderian, Olga Shestova, et al.
Cancer Immunology Research|July 22, 2018
Reducing <i>Ex Vivo</i> Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T CellsSaba Ghassemi, Selene Nunez-Cruz, Roddy S O'Connor, et al.
Pageof 3